About InOncology
InOncology is a Healthcare company founded in 2009. It develops innovative immunotherapies for cancer treatment. It operates on a B2B model. Its focus areas include Biotechnology, Pharmaceuticals and Immunotherapy.
Company details
InOncology develops innovative immunotherapies for cancer treatment through providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and immunotherapy. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- SectorsHealthcare
- Website inoncology.com
Web traffic of InOncology
Websites that share an audience with InOncology (inoncology.com).
Websites whose visitors overlap most with InOncology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| vhio.net | 84% | 86.9K | #388,215 | View details | |
| xstrahl.com | 62% | 4.8K | #4,200,261 | View details | |
| asco.org | 62% | 552.2K | #102,599 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about InOncology
InOncology was founded in 2009.
InOncology develops innovative immunotherapies for cancer treatment through providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and immunotherapy. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.